{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:31:18Z","timestamp":1778873478511,"version":"3.51.4"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Ross River virus (RRV) is an endemic Australian arbovirus, and member of the Alphavirus family that also includes Chikungunya virus (CHIK). RRV is responsible for the highest prevalence of human disease cases associated with mosquito-borne transmission in Australia, and has long been a leading suspect in cases of post-viral fatigue syndromes, with extrapolation of this link to Myalgic Encephalomyelitis (ME). Research into RRV pathogenesis has revealed a number of immune evasion strategies, impressive for a virus with a genome size of 12 kb (plus strand RNA), which resonate with insights into viral pathogenesis broadly. Drawing from observations on RRV immune evasion, mechanisms of relevance to long term idiopathic fatigue are featured as a perspective on infection and eventual ME symptoms, which include considerations of; (1) selective pro-inflammatory gene suppression post antibody-dependent enhancement (ADE) of RRV infection, (2) Evidence from other virus families of immune disruption and evasion post-ADE, and (3) how virally-driven immune evasion may impact on mitochondrial function via target of rapamycin (TOR) complexes. In light of these RRV measures to counter the host immune - inflammatory responses, links to recent discoveries explaining cellular, immune and metabolomic markers of ME will be explored and discussed, with the implications for long-COVID post SARS-CoV-2 also considered. Compelling issues on the connections between virally-induced alterations in cytokine expression, for example, will be of particular interest in light of energy pathways, and how these perturbations manifest clinically.<\/jats:p>","DOI":"10.3389\/fmed.2021.662513","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T06:12:47Z","timestamp":1616566367000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Ross River Virus Immune Evasion Strategies and the Relevance to Post-viral Fatigue, and Myalgic Encephalomyelitis Onset"],"prefix":"10.3389","volume":"8","author":[{"given":"Brett A.","family":"Lidbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/diagnostics9030091","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review","volume":"9","author":"Cortes Rivera","year":"2019","journal-title":"Diagnostics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: international consensus criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Intern Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10067-018-4009-2","article-title":"On chronic fatigue syndrome and nosological categories","volume":"37","author":"Sharif","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0166-0934(88)90047-X","article-title":"Chronic fatigue syndromes: relationship to chronic viral infections","volume":"21","author":"Komaroff","year":"1988","journal-title":"J Virol Methods"},{"key":"B5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12967-018-1644-y","article-title":"Chronic viral infections in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"16","author":"Rasa","year":"2018","journal-title":"J Transl Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12967-020-02585-5","article-title":"Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome","volume":"18","author":"Raijmakers","year":"2020","journal-title":"J Transl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"key":"B8","volume-title":"Field's Virology","author":"Knipe","year":"2013"},{"key":"B9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1146\/annurev.immunol.18.1.861","article-title":"Viral subversion of the immune system","volume":"18","author":"Tortorella","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1189\/jlb.0705397","article-title":"Viral strategies for evading antiviral cellular immune responses of the host","volume":"79","author":"Iannello","year":"2006","journal-title":"J Leukoc Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1126\/science.1455233","article-title":"Encoding of a homolog of the IFN-gamma receptor by Myxoma virus","volume":"258","author":"Upton","year":"1992","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0092-8674(92)90274-G","article-title":"A soluble receptor for interieukin-1\u03b2 encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection","volume":"71","author":"Alcami","year":"1992","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1126\/science.2161559","article-title":"Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Ban- virus gene BCRFI","volume":"248","author":"Moore","year":"1990","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/infdis\/162.2.331","article-title":"Glycoprotein C of herpes simplex virus, type I prevents complement-mediated cell lysis and virus neutralisation","volume":"162","author":"Harris","year":"1990","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/icb.1994.52","article-title":"Was exposure to directly antiviral cytokines during primary infection an important selective pressure in the evolution of unique immune evasion strategies by viruses?","volume":"72","author":"Lidbury","year":"1994","journal-title":"Immunol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1440-1711.2001.00973.x","article-title":"Genetic \u201cbudget\u201d of viruses and the cost to the infected host: a theory on the relationship between the genetic capacity of viruses, immune evasion, persistence and disease","volume":"79","author":"Chaston","year":"2001","journal-title":"Immunol Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1189\/jlb.72.3.429","article-title":"The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses","volume":"72","author":"Mahalingam","year":"2002","journal-title":"J Leukoc Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"582061","DOI":"10.3389\/fimmu.2020.582061","article-title":"Zika virus inhibits IFN-\u03b1 response by human plasmacytoid dendritic cells and induces NS1-dependent triggering of CD303 (BDCA-2) signaling","volume":"11","author":"Bos","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.vaccine.2012.11.015","article-title":"Immune evasion strategies of flaviviruses","volume":"31","author":"Ye","year":"2013","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2135","article-title":"Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV","volume":"30","author":"Bouayad","year":"2020","journal-title":"Rev Med Virol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"580641","DOI":"10.3389\/fimmu.2020.580641","article-title":"Covid-19: perspectives on innate immune evasion","volume":"11","author":"Taefehshokr","year":"2020","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1128\/CMR.14.4.909-932.2001","article-title":"Ross river virus transmission, infection, and disease: a cross-disciplinary review","volume":"14","author":"Harley","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nrrheum.2012.64","article-title":"Arthritogenic alphaviruses\u2013an overview","volume":"8","author":"Suhrbier","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/d41586-020-02796-2","article-title":"Long COVID: let patients help define long-lasting COVID symptoms","volume":"586","author":"Nature","year":"2020","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/icb.1964.44","article-title":"Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls","volume":"42","author":"Hawkes","year":"1964","journal-title":"Aust J Exp Biol Med Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/0042-6822(67)90144-4","article-title":"The enhancement of virus infectivity by antibody","volume":"33","author":"Hawkes","year":"1967","journal-title":"Virology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/289189a0","article-title":"Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages","volume":"289","author":"Peiris","year":"1981","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1099\/0022-1317-64-6-1255","article-title":"17D yellow fever virus infection of P388D1 cells mediated by monoclonal antibodies: properties of the macrophage Fc receptor","volume":"64","author":"Schlesinger","year":"1983","journal-title":"J Gen Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue haemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.ebiom.2020.102991","article-title":"Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models","volume":"60","author":"Shukla","year":"2020","journal-title":"EBioMedicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/088282403763635465","article-title":"Antibody-dependent enhancement of virus infection and disease","volume":"16","author":"Tirado","year":"2003","journal-title":"Viral Immunol"},{"key":"B34","first-page":"335","article-title":"Antibody-dependent enhancement of viral infectivity","volume-title":"Advances in Virus Research","author":"Porterfield","year":"1986"},{"key":"B35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1099\/0022-1317-77-3-407","article-title":"Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis","volume":"77","author":"Linn","year":"1996","journal-title":"J Gen Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8376","DOI":"10.1128\/JVI.74.18.8376-8381.2000","article-title":"Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection","volume":"74","author":"Lidbury","year":"2000","journal-title":"J Virol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13819","DOI":"10.1073\/pnas.202415999","article-title":"Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus","volume":"99","author":"Mahalingam","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1099\/vir.0.82537-0","article-title":"Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells","volume":"88","author":"Chareonsirisuthigul","year":"2007","journal-title":"J Gen Virol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"17306","DOI":"10.1074\/jbc.M115.664136","article-title":"Spleen tyrosine kinase (Syk) mediates IL-1\u03b2 induction by primary human monocytes during antibody-enhanced dengue virus infection","volume":"290","author":"Callaway","year":"2015","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"22303","DOI":"10.1038\/srep22303","article-title":"Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy","volume":"6","author":"Huang","year":"2016","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1423-0127-20-40","article-title":"An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection","volume":"20","author":"Tsai","year":"2013","journal-title":"J Biomed Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e3320","DOI":"10.1371\/journal.pntd.0003320","article-title":"Antibody-dependent enhancement infection facilitates dengue virus-regulated signalling of IL-10 production in monocytes","volume":"8","author":"Tsai","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/v12020187","article-title":"Antibody-mediated porcine reproductive and respiratory syndrome virus infection downregulates the production of interferon-\u03b1 and tumor necrosis factor-\u03b1 in porcine alveolar macrophages via Fc gamma receptor I and III","volume":"12","author":"Zhang","year":"2020","journal-title":"Viruses"},{"key":"B44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.vetimm.2004.09.017","article-title":"Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection","volume":"102","author":"Cancel-Tirado","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.vetimm.2013.09.006","article-title":"Antibody-dependent enhancement of PRRSV infection down-modulates TNF-\u03b1 and IFN-\u03b2 transcription in macrophages","volume":"156","author":"Bao","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e28721","DOI":"10.1371\/journal.pone.0028721","article-title":"Porcine Fc\u03b3RIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection","volume":"6","author":"Qiao","year":"2011","journal-title":"PLoS ONE"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3389\/fimmu.2018.02860","article-title":"How dengue virus circumvents innate immunity","volume":"9","author":"Kao","year":"2018","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.1128\/JVI.74.15.7146-7150.2000","article-title":"Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell\/basophil line","volume":"74","author":"King","year":"2000","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0008602","DOI":"10.1371\/journal.pntd.0008602","article-title":"A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection","volume":"14","author":"Furuyama","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1006139","DOI":"10.1371\/journal.ppat.1006139","article-title":"Fc\u03b3-receptor IIa-mediated Src signaling pathway Is essential for the antibody-dependent enhancement of Ebola virus infection","volume":"12","author":"Furuyama","year":"2016","journal-title":"PLoS Pathog"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.1086\/520581","article-title":"Epitopes required for antibody-dependent enhancement of Ebola virus infection","volume":"196","author":"Takada","year":"2007","journal-title":"J Infect Dis"},{"key":"B52","first-page":"25","article-title":"Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS","volume":"22","author":"Yip","year":"2016","journal-title":"Hong Kong Med J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"Virol J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1128\/JVI.00671-11","article-title":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway","volume":"85","author":"Jaume","year":"2011","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbalip.2014.12.006","article-title":"PI3K signalling in inflammation","volume":"1851","author":"Hawkins","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellimm.2017.11.009","article-title":"Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses","volume":"324","author":"Bradley","year":"2018","journal-title":"Cell Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"155256","DOI":"10.1016\/j.cyto.2020.155256","article-title":"ADE and hyperinflammation in SARS-CoV2 infection - comparison with dengue hemorrhagic fever and feline infectious peritonitis","volume":"136","author":"Cloutier","year":"2020","journal-title":"Cytokine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e01083","DOI":"10.1128\/JVI.01083-20","article-title":"COVID-19 vaccines: \u201cWarp Speed\u201d needs mind melds, not warped minds","volume":"94","author":"Moore","year":"2020","journal-title":"J Virol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7196\/SAMJ.2020.v111i11.15433","article-title":"Long-COVID: An evolving problem with an extensive impact","volume":"111","author":"Mendelson","year":"2020","journal-title":"S Afr Med J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12967-019-1948-6","article-title":"The clinical value of cytokines in chronic fatigue syndrome","volume":"17","author":"Yang","year":"2019","journal-title":"J Transl Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbi.2015.07.004","article-title":"Chronic fatigue syndrome and circulating cytokines: a systematic review","volume":"50","author":"Blundell","year":"2015","journal-title":"Brain Behav Immun"},{"key":"B63","first-page":"1","article-title":"Chronic fatigue syndrome and mitochondrial dysfunction","volume":"2","author":"Myhill","year":"2009","journal-title":"Int J Clin Exp Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0186802","DOI":"10.1371\/journal.pone.0186802","article-title":"Cellular bioenergetics is impaired in patients with chronic fatigue syndrome","volume":"12","author":"Tomas","year":"2017","journal-title":"PLoS ONE"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cca.2012.06.022","article-title":"NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome","volume":"413","author":"Armstrong","year":"2012","journal-title":"Clin Chim Acta"},{"key":"B66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/B978-0-12-801401-1.00005-0","article-title":"Metabolism in chronic fatigue syndrome","volume":"66","author":"Armstrong","year":"2014","journal-title":"Adv Clin Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/ijms21031074","article-title":"An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME\/CFS patients","volume":"21","author":"Missailidis","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/ijms21031142","article-title":"Cell-based blood biomarkers for myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"21","author":"Missailidis","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1534\/genetics.111.133363","article-title":"Target of rapamycin (TOR) in nutrient signaling and growth control","volume":"189","author":"Loewith","year":"2011","journal-title":"Genetics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000484629","article-title":"mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review","volume":"64","author":"Weichhart","year":"2018","journal-title":"Gerontology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.it.2014.10.006","article-title":"Intersection of mTOR and STAT signaling in immunity","volume":"36","author":"Saleiro","year":"2015","journal-title":"Trends Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.4049\/jimmunol.1601066","article-title":"Epithelial TNF receptor signaling promotes mucosal repair in inflammatory bowel disease","volume":"199","author":"Bradford","year":"2017","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/ijms19071959","article-title":"Transmembrane TNF and partially TNFR1 regulate TNFR2 expression and control inflammation in mycobacterial-induced pleurisy","volume":"19","author":"Uysal","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12967-017-1161-4","article-title":"Activin B is a novel biomarker for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) diagnosis: a cross sectional study","volume":"15","author":"Lidbury","year":"2017","journal-title":"J Transl Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mce.2011.10.009","article-title":"The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair","volume":"359","author":"de Kretser","year":"2012","journal-title":"Mol Cell Endocrinol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.662513\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T06:12:54Z","timestamp":1616566374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.662513\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":75,"alternative-id":["10.3389\/fmed.2021.662513"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.662513","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"article-number":"662513"}}